Clinical Trial Update: Comparison of Cilotax Stent and Everolimus -Eluting Stent With Diabetes Mellitus (ESSENCE-DM III) [Phase 4]

View source ↗

Summary

A Phase 4 trial compares the Cilotax stent to an Everolimus-eluting stent in patients with coronary artery disease, including those with diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Cilotax Stent
• Everolimus-eluting stent (everolimus-eluting stent)

Snippet

Sponsor: CHEOL WHAN LEE, MD, PhD. | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED